RHAMM (CD168) is overexpressed at the protein level and may constitute an immunogenic antigen in advanced prostate cancer disease

Kilian M. Gust, Matthias D. Hofer, Sven R. Perner, Robert Kim, Arul M. Chinnaiyan, Sooryanarayana Varambally, Peter Moller, Ludwig Rinnab, Mark A. Rubin, Jochen Greiner, Michael Schmitt, Rainer Kuefer*, Mark Ringhoffer

*Corresponding author for this work
49 Citations (Scopus)

Fingerprint

Dive into the research topics of 'RHAMM (CD168) is overexpressed at the protein level and may constitute an immunogenic antigen in advanced prostate cancer disease'. Together they form a unique fingerprint.

Medicine and Dentistry

Immunology and Microbiology

Biochemistry, Genetics and Molecular Biology

Pharmacology, Toxicology and Pharmaceutical Science